Melanoma thickness and histology predict sentinel lymph node status.

[1]  Russell‐Jones.  Interferon‐α therapy for melanoma , 2000 .

[2]  D L Morton,et al.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. , 1999, Annals of surgery.

[3]  D. Morton,et al.  Efficacy of Lymphatic Mapping, Sentinel Lymphadenectomy, and Selective Complete Lymph Node Dissection as a Therapeutic Procedure for Early-Stage Melanoma , 1999, Annals of Surgical Oncology.

[4]  D. Dabrowska,et al.  Identifying predictive factors in melanoma progression. , 1998, Oncology reports.

[5]  N. Cascinelli,et al.  Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial , 1998, The Lancet.

[6]  D. Reintgen.  Lymphatic mapping and sentinel node harvest for malignant melanoma , 1997, Journal of surgical oncology.

[7]  M. Mihm,et al.  Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. , 1996, Annals of surgery.

[8]  D. Weaver,et al.  Minimal-access surgery for staging of malignant melanoma. , 1995, Archives of surgery.

[9]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[10]  A. Halpern,et al.  Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.

[11]  X. Ji,et al.  Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma. , 1988, American journal of clinical pathology.

[12]  F. Sim,et al.  Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. , 1986, Mayo Clinic proceedings.

[13]  R. Gaynor,et al.  S100 PROTEIN: A MARKER FOR HUMAN MALIGNANT MELANOMAS? , 1981, The Lancet.

[14]  C. Balch,et al.  A Multifactorial Analysis of Melanoma: III. Prognostic Factors in Melanoma Patients with Lymph Node Metastases (Stage II) , 1981, Annals of surgery.

[15]  T. K. Gupta.  Results of treatment of 269 patients with primary cutaneous melanoma: a five-year prospective study. , 1977, Annals of surgery.

[16]  Callaway Cw,et al.  Letter: Diabetic ketoacidosis. , 1974, Lancet.

[17]  A. Giuliano,et al.  Radiation Safety Considerations for Sentinel Node Techniques , 1999, Annals of Surgical Oncology.